Trend Signal Now: The Hot Corner: Biotech, Private Credit

Tuesday, March 10, 2026

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

📌 Lyell Immunopharma $LYEL — Paul L. Berns purchased $12.50 Million via Form 4.

A major insider commitment in the micro-cap immunotherapy biotech that attempts to complete a deep bearish-to-bullish reversal.

📌 Sixth Street Specialty Lending $TSLX — Alan Waxman purchased $5.53 Million via Form 4.

Massive insider accumulation in the private credit vehicle as the space remains in the crosshairs.

Here's The Hot Corner, with data from March 9, 2026:

Click the table to enlarge it.

📌 Ouster $OUST — Virginia Boulet bought $136,175 per Form 4.

A small but notable insider buy in the lidar technology company, as the stock continues carving out a potential SPAC-era reversal base after a long period of consolidation.

📌 Tennant $TNC — GAMCO Investors increased its 13D stake from 2.72% to 5.00%.

The value-focused investment firm crossed the key 5% ownership threshold in the industrial cleaning equipment manufacturer, signaling a more meaningful position.

📌 Bally's $BALY — Whitefort Capital increased its 13G stake from 3.91% to 5.10%.

The institutional investor also moved above the 5% mark, building a larger position in the casino operator as the stock continues to chop within a multi-year range.

If you want this actionable trade ideas based on insider trading, join Hot Corner Insider risk-free.

Get access to Wave Trader for 63% OFF

Wave Trader is a new way to trade options, and it is already pumping out winning trades. Get in while the offer lasts.

Alfonso De Pablos | Director of Research, All Star Charts

Stock Market Media emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of Stock Market Media LLC or its affiliates (collectively, "Stock Market Media") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from Stock Market Media may be monitored or reviewed at Stock Market Media's discretion. Stock Market Media accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by Stock Market Media.

Want to change how you receive these emails? You can manage your preferences here unsubscribe.

© 2026 Stock Market Media 624 Broadway, Suite 405 San Diego, CA 92101